ClinicalTrials.Veeva

Menu

Exploring Men s Prostate Cancer Genetic Risk Perceptions

H. Lee Moffitt Cancer Center and Research Institute logo

H. Lee Moffitt Cancer Center and Research Institute

Status

Completed

Conditions

Prostate Cancer

Treatments

Other: Saliva Sample
Other: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT06764992
MCC-21876

Details and patient eligibility

About

The exploring men's prostate cancer genetic risk perceptions and willingness to give a biospecimen for genetic risk testing study aims to assess prostate cancer genetic risk and susceptibility beliefs among unaffected men of diverse races/ethnicities who are considering undergoing prostate cancer screening and their willingness of men to provide a biospecimen (saliva sample) and test the samples for prostate cancer aggressiveness and determine risk category based on SNP genetic profile.

Enrollment

100 patients

Sex

Male

Ages

40+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Racially/ethnically diverse men with emphasis on Men of African Ancestry.
  • Age 40 and older .
  • No personal prostate cancer history/diagnosis.
  • With or without family history of prostate cancer.

Exclusion criteria

  • Previous personal Prostate Cancer history/diagnosis
  • Under 40 years of age

Trial design

100 participants in 1 patient group

Prostate Cancer Risk Group
Description:
Participants will be asked to provide saliva samples and complete a questionnaire about their Prostate Cancer Genetic Risk beliefs.
Treatment:
Other: Questionnaire
Other: Saliva Sample

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems